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aIn  this  report,  I  have  tried  to  identify  some  common  themes
of  the  meeting,  which  span  multiple  talks.  I  also  pick  out
a  few  highlights,  as  identiﬁed  by  other  participants,  using
anonymous  forms  I  circulated  at  the  meeting.  Some  presen-
ters’  names  are  mentioned,  but  this  is  purely  for  illustration.
I  do  not  wish  to  imply  that  other  talks  were  not  equally  as
informative  and  interesting.  I  hope  this  format  will  be  more
useful  to  readers  than  the  commonly  found  pattern  of  a few
sentences  summarizing  each  talk  —  the  presenters  them-
selves  offer  such  abstracts  in  the  program  and  proceedings.
Several  speakers  noted  the  sad  recent  premature  death
of  Richard  Armstrong,  for  some  time  a  leading  light  of  the
STRENDA  Commission,  and  a  regular  participant  in  ESCEC
meetings.  He  will  be  greatly  missed.
Understanding the sequence—function
relationship
Better  understanding  of  how  sequence  determines  enzyme
function  is  clearly  a  fundamental  challenge  for  pure  enzy-
mology.  But  it  would  also  beneﬁt  other  ﬁelds  in  which  better
tools  to  predict  function  from  sequence  would  be  really
valuable.  These  include  the  annotation  of  gene  sequences,
assignment  of  the  metabolic  role  of  enzymes,  identiﬁcation
of  novel  enzymes  for  applied  biocatalysis,  and  understanding
the  evolutionary  history  of  enzymes.  Findings  from  studies
in  these  complementary  ﬁelds  also  provide  useful  data  that
can  help  with  the  fundamental  aim.  So  all  of  these  ﬁelds,
and  probably  others,  have  shared  interests  in  understanding
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(http://creativecommons.org/licenses/by/4.0/).he  landscape  for  how  enzyme  function  depends  on  structure
nd  ultimately  sequence.
Approaches  to  clustering  sequences  that  may  reveal
lasses  sharing  (almost)  identical  functions  were  presented
t  the  meeting.  However,  speakers  also  pointed  out  that  in
ome  cases  very  small  changes  in  sequence  were  enough
o  alter  function  substantially.  Hence,  in  many  cases  the
elationship  needs  to  be  approached  by  understanding  the
eterminants  and  consequences  of  3D  structure.
All  of  these  ﬁelds  generate  potentially  useful  information
or  this  purpose  from  experiments  where  protein  sequences
re  changed  in  the  laboratory,  and  the  effect  on  function
s  measured.  The  speciﬁc  aims  of  the  experiments  may
ary  very  widely,  from  understanding  evolutionary  history  to
aking  more  practically  useful  catalysts—examples  of  both
f  these  were  presented  at  the  meeting.  But  all  these  stud-
es  can  feed  in  to,  and  beneﬁt  from,  better  understanding
f  the  structural  determinants  of  function.
ene annotation
any  presenters  noted  the  importance  of  enzymology  in
unctional  annotation  of  the  ever-increasing  volume  of
equence  data.  Currently,  many  genes  for  enzymes  are
nnotated  based  just  on  super-family  identiﬁcation,  giving
n  activity  that  is  common,  typical  or  even  just  historically
mportant  for  the  group.  Perhaps  the  best  illustration  was
resented  by  Karen  Allen  in  a  comprehensive  study  of  over
00  members  of  the  haloalkanoate  dehalogenase  superfa-
ily.  In  fact,  haloalkanoate  dehalogenases  make  up  only
%  of  the  characterized  members  of  the  superfamily,  and
he  newly  studied  enzymes  showed  phosphoryl  transfer  or
hosphohydrolase  activity  on  a  wide  range  of  phosphory-
ated  metabolites.  Another  example  is  the  100  000+  member
midohydrolase  superfamily,  many  of  whose  sequences  are
urrently  wrongly  annotated  as  adenosine  deaminase,  a
lassic  member  of  the  superfamily.  Frank  Raushel  described
xperimental  studies  assigning  much  more  precise  functions
 an open access article under the CC BY license.
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or  representatives  of  sequence  clusters  in  the  superfamily.
any  speakers  agreed  that  a  high  proportion  of  enzyme
enes  were  wrongly  or  incompletely  annotated  —  the  exact
ercentage  depends  on  the  precision  with  which  annota-
ion  is  required  before  classing  it  as  correct.  Much  of  the
ecent  progress  in  this  area  was  attributed  to  the  US  Enzyme
unction  Initiative  (EFI),  unfortunately  now  coming  to  an
nd.
nzyme ‘‘promiscuity’’
ndividual  enzymes  that  are  able  to  catalyze  reactions  on  a
ide  range  of  different  substrate  structures  were  discussed.
any  refer  to  this  broad  speciﬁcity  as  promiscuity,  although
t  was  noted  that  others  favor  a  tighter  deﬁnition  of  this
erm.  Ability  to  accept  a  wide  range  of  natural  metabolites
eems  quite  common  among  enzymes,  although  the  physi-
logical  role  of  this  is  still  usually  a  matter  of  speculation.
he  phenomenon  is  long-known  for  extracellular  hydrolases,
here  it  has  clear  selective  beneﬁts  in  nutrient  acquisition.
ut  examples  were  presented  of  its  occurrence  in  cytosolic
nzymes,  where  evolutionary  pressures  for  high  selectivity
nd  speciﬁcity  might  be  expected.  Broad  speciﬁcity  is  often
ttractive  in  enzymes  to  be  used  as  preparative  catalysts,  to
llow  application  in  making  a  range  of  molecules,  while  pre-
erving  some  key  features  like  enantioselectivity.  Examples
ere  shown  of  standard  metabolic  enzymes,  like  aldolases,
hat  have  found  industrial  application  on  many  non-natural
ubstrates.  There  is  of  course  no  particular  selective  pres-
ure  to  accept  or  reject  substrate  molecules  never  found  in
ature.
nterdisciplinary exchanges: enzymes to
athways and  products
ne  feature  of  these  ESCEC  meetings  is  that  they  bring
ogether  people  from  different  research  communities,  who
ave  overlapping  interests,  but  would  not  often  meet.  This
as  favorably  commented  on  by  a  number  of  participants,
ome  identifying  such  interdisciplinary  exchanges  as  the
ost  useful  things  learned  at  the  meeting.  This  meet-
ng  prompted  useful  exchanges  between  scientists  from
ure  enzymology,  systems  biology,  medicinal  chemistry,
etabolism,  applied  biocatalysis,  theoretical  biology  and
thers.  At  the  same  time,  the  lack  of  regular  exchanges
etween  these  communities  may  well  mean  opportunities
o  beneﬁt  each  of  them  are  being  missed.  One  attendee
ommented:  ‘‘I  had  the  feeling  that  some  aspects  are  inves-
igated  in  parallel  (which  is  not  very  efﬁcient)  or  without  the
nowledge  of  the  other  community.’’
Many  participants  had  a  core  interest  in  fundamental
nzymology,  of  course.  Another  well  represented  ﬁeld  was
ystems  biology,  as  clearly  implied  by  the  sub-title  of  the
eeting.  Another  strong  theme  on  this  occasion  was  the  use
f  enzymes  to  create  economic  beneﬁts.  Their  use  as  practi-
al  catalysts,  and  in  medical  treatments,  is  noted  elsewhere
n  this  report.A  further  important  link  was  the  relationship  of  enzymes
o  pathways.  An  important  motivation  for  studying  enzymes
s  to  understand  how  their  activity  ﬁts  into  metabolic  path-
ays.  Indeed,  this  ultimately  should  be  the  target  of  gene
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nnotation  (see  above).  Many  speakers  contributed  on  this
ssue,  and  for  some  this  was  the  main  focus  of  their  work  and
resentation.  Of  course,  systems  biology  is  usually  focused
n  metabolic  pathways  and  networks.  Some  presentations
ointed  to  the  possible  complexity  of  conﬁdently  identify-
ng  metabolic  function.  In  both  natural  organisms,  and  those
hat  had  been  subject  to  forced  selective  pressure  in  the
aboratory,  it  was  possible  to  ﬁnd  enzymes  that  had  been
‘re-purposed’’  to  enable  a  useful  metabolic  pathway—a  rel-
tively  minor  secondary  activity  of  the  enzyme  was  now
laying  a  key  role  in  allowing  a  pathway  to  proceed.
ata handling
ne  natural  focus  of  the  meeting  was  recording,  validat-
ng,  storing,  searching  and  exchanging  data  in  enzymology.
 demonstration  showed  a fairly  robust  trial  version  of
he  STRENDA  DB  system  to  collect  enzyme  function  data
nd  conﬁrm  its  compliance  with  the  STRENDA  guidelines.
articipants  were  invited  to  test  the  system  thoroughly
https://www.beilstein-strenda-db.org/strenda/) and  feed-
ack  comments.  A  number  of  targets  for  enhancement  of  the
asic  system  had  already  been  noted.  A  wider  theme  was
he  need  to  ensure  better  integration  between  the  various
atabases  holding  information  relevant  to  enzymology.  This
ncludes  not  only  those  focused  on  enzymes  like  BRENDA
nd  SABIO-RK,  but  also  those  covering  related  topics  like
equence,  structure,  metabolism,  systems  biology  and  mod-
ling,  synthetic  biology  and  small  molecules  that  interact
ith  proteins.  One  example  was  the  Reactome  database  of
uman  genes,  presented  by  Henning  Hermjakob,  which  aims
o  integrate  function  knowledge,  including  small  molecule
nteractions  and  disease  linkages.
The  importance  of  recording  data  for  ‘‘negative  results’’
hat  might  never  make  it  to  a  normal  publication  was  noted.
n  understanding  the  relationship  of  sequence/structure  to
unction,  for  example,  mutations  that  reduce  activity  may
e  as  informative  as  those  that  increase  it.  Yet  such  results
re  unlikely  to  be  published  in  the  usual  literature.
ransferable experimental tools: sequence
ibraries and function screening
everal  participants  commented  that  they  could  identify
pportunities  to  transfer  conceptual  and  experimental  tools
nd  approaches  across  ﬁelds.  For  different  reasons  it  is  of
nterest  to  modify  protein  sequences  in  the  lab  and  study
he  effects  on  function.  Changes  range  from  single  muta-
ions  to  recombination  of  two  or  more  related  sequences.
nd  the  changes  may  be  selected  more  or  less  ratio-
ally,  or  with  a  greater  degree  of  randomness  (in  directed
volution).  A  number  of  speakers  reported  the  use  of  com-
utational  tools  for  optimal  design  of  altered  sequence
ibraries  in  such  studies.  Other  participants  noted  that  they
ould  foresee  useful  applications  for  such  tools  in  different
ub-ﬁelds.
Such  sequence  alteration  is  usually  followed  by  screening
or  activity  or  other  functional  properties.  Tools  and  meth-
ds  for  the  screening  of  enzyme  activity  are  of  interest
rom  several  distinct  communities.  In  all  of  these  there
s  often  a  wish  for  automated,  high-throughput  methods
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that  can  be  applied  to  thousands  or  more  samples.  In
attempts  to  improve  gene  annotation  the  samples  will  be
natural  sequences,  typically  chosen  to  be  representative
from  clusters  of  similar  sequences.  In  studies  aimed  at
improved  understanding  of  enzyme  activity  and  speciﬁcity,
samples  will  typically  contain  mutations  or  recombinations
introduced  from  starting  sequences.  In  applied  biocatalysis
the  aim  will  be  to  identify  improved  function  as  preparative
catalysts,  with  test  sequences  from  known  genomes,  from
environmental  DNA  (metagenomics  studies)  or  with  labora-
tory  introduced  changes.  The  conference  heard  of  studies
from  all  these  communities  that  had  employed  (relatively)
high  throughput  methods.  Some  useful  transfers  of  knowl-
edge  on  such  methods  took  place,  but  there  are  probably
further  opportunities  here.
For  many  applications  we  need  good  quantitative  under-
standing  of  enzyme  function,  so  kinetic  models  and
approaches  are  an  important  topic.  The  meeting  heard
about  some  novel  suggestions  here.  A  mathematical  treat-
ment  of  the  simple  Henri-Michaelis-Menten-Briggs-Haldane
kinetic  network  can  avoid  the  steady-state  and  other
approximations.  This  led  to  a  proposed  method  to  analyze
experimental  data  in  terms  of  three  parameters,  including
the  true  KS for  dissociation  of  the  enzyme-substrate  com-
plex.  Consideration  of  enzyme  competition  for  sites  on  the
surface  of  a  solid-phase  substrate  led  to  a  kinetic  model
able  to  describe  observations  on  starch  degradation.  The
model  should  be  much  more  widely  applicable,  however,
whenever  enzymes  act  on  insoluble  substrates.  Finally,  sys-
tems  involving  redox  protein  cycling  can  show  apparently69
ichaelis-Menten  behavior  even  when  individual  reaction
teps  do  not  show  saturation  kinetics.
inking enzymology to practical applications
s  noted  above,  the  meeting  involved  presentations  on  what
nzymes  can  offer  as  preparative  catalysts.  Daniel  Mink
rom  the  DSM  company  showed  a large  number  of  pro-
esses  operating  industrially  at  scales  up  to  thousands  of
ons  of  products.  But  the  more  traditional  applications  of
nzymology  in  medical  applications  were  also  covered.  Bar-
ara  Bakker  presented  work  combining  enzymology  with
 quantitative  systems  biology  model  to  understand  the
ffects  of  an  inherited  deﬁciency  in  medium  chain  acyl-CoA
ehydrogenase.  Under  most  circumstances  mitochondrial
eta-oxidation  would  still  proceed  efﬁciently,  but  in  some
onditions  the  result  could  be  a  catastrophic  loss  of  ﬂux.
ost  impressively,  this  was  the  basis  for  a  simple  treat-
ent  plan  for  sufferers,  which  should  prevent  a  signiﬁcant
ause  of  sudden  infant  death.  Other  applications  pre-
ented  included  asparaginase  derivatives  for  injection  as
nti-leukemia  treatments,  and  luciferases  as  reporters  in
creening  of  effects  on  gene  expression.
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